Mohammadi-Khanaposhtani_2022_Arch.Pharm.(Weinheim)__e2100313

Reference

Title : New 4-phenylpiperazine-carbodithioate-N-phenylacetamide hybrids: Synthesis, in vitro and in silico evaluations against cholinesterase and alpha-glucosidase enzymes - Mohammadi-Khanaposhtani_2022_Arch.Pharm.(Weinheim)__e2100313
Author(s) : Mohammadi-Khanaposhtani M , Nori M , Valizadeh Y , Javanshir S , Dastyafteh N , Moaazam A , Hosseini S , Larijani B , Adibi H , Biglar M , Hamedifar H , Mahdavi M , Kamci H , Karakus A , Taslimi P
Ref : Arch Pharm (Weinheim) , :e2100313 , 2022
Abstract : Mohammadi-Khanaposhtani_2022_Arch.Pharm.(Weinheim)__e2100313
ESTHER : Mohammadi-Khanaposhtani_2022_Arch.Pharm.(Weinheim)__e2100313
PubMedSearch : Mohammadi-Khanaposhtani_2022_Arch.Pharm.(Weinheim)__e2100313
PubMedID: 35132681

Related information

Citations formats

Mohammadi-Khanaposhtani M, Nori M, Valizadeh Y, Javanshir S, Dastyafteh N, Moaazam A, Hosseini S, Larijani B, Adibi H, Biglar M, Hamedifar H, Mahdavi M, Kamci H, Karakus A, Taslimi P (2022)
New 4-phenylpiperazine-carbodithioate-N-phenylacetamide hybrids: Synthesis, in vitro and in silico evaluations against cholinesterase and alpha-glucosidase enzymes
Arch Pharm (Weinheim) :e2100313

Mohammadi-Khanaposhtani M, Nori M, Valizadeh Y, Javanshir S, Dastyafteh N, Moaazam A, Hosseini S, Larijani B, Adibi H, Biglar M, Hamedifar H, Mahdavi M, Kamci H, Karakus A, Taslimi P (2022)
Arch Pharm (Weinheim) :e2100313